Project Grant R35GM162529
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Leland Stanford Junior University a Project Grant of $2.1M (CFDA 93.859, Biomedical Research and Research Training) effective September 11, 2025, through August 31, 2029, to support research on the genetic basis of complex traits. The research focuses on developing and refining experimental and computational methods to identify genes and genetic variants underlying complex polygenic traits across...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stanford University a $410,256 Project Grant on September 15, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop generative multiscale models of biomolecular conformational dynamics. Over the five-year project period through July 31, 2030, Stanford will deliver computational tools that integrate physics-based modeling with artificial intelligence to...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $363,570 Project Grant to the University of California, Los Angeles (UCLA) effective March 15, 2026, through February 28, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds the development of integrative computational and analytical methods to reconstruct three-dimensional (3D) genome structures from single cells by combining imaging data with...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stanford University a $616,000 Project Grant on March 12, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop next-generation proximity labeling (PL) enzymes for mapping spatial proteomes in living cells. The research deliverables include the optimization and engineering of two novel PL enzymes—FLEXID and LACCID—designed to overcome limitations of existing...
- Federal Project Grant Award Summary Stanford University received a $462,119 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 8, 2025, with completion targeted for July 31, 2029. The award funds development and deployment of Transposon Accelerated Chromatin Kinetic Imaging Technology (TRACK-IT), a next-generation live-imaging platform designed to map...
- Federal Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded The Leland Stanford Junior University a $721,450 Project Grant (CFDA 93.172: Human Genome Research) effective March 1, 2026, through February 28, 2030, to develop genome-wide maps linking enhancer variants to gene regulatory functions. The project will deliver three primary products: (1) a computational model optimized to predict enhancer-gene (E-G) regulatory interactions from single-cell multiomics...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stanford University a $427,079 Project Grant effective August 1, 2025, through July 31, 2027, under the Biomedical Research and Research Training program (CFDA 93.859). The project, titled "DNA Transistors for Cellular Programming," focuses on developing innovative molecular tools that enable precise control over cellular functions using DNA-binding domains derived from nuclease technologies,...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Leland Stanford Junior University a $303,364 Project Grant on May 15, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and apply advanced microfluidic technologies for accelerated enzyme function analysis. The project, titled "Dissecting Enzyme Function at Scale Using Synergistic Advances in Microfluidics and Genetic Code Expansion,"...
- Federal Project Grant Award Summary Carnegie Institution for Science received a $335,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 9, 2025, with a completion date of August 31, 2026. The award funds fundamental research investigating the mechanisms by which lamins—Type V intermediate filament nuclear proteins—regulate three-dimensional (3D) genome organization and gene...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $385,000 Project Grant to The Leland Stanford Junior University effective September 1, 2025, through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports fundamental research to identify and characterize novel lipid transport and processing mechanisms evolved by Plasmodium parasites that interface with human cell physiology. The research...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $385,000 to The Leland Stanford Junior University, effective March 1, 2026, through December 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research to elucidate the physical and chemical principles governing three-dimensional (3D) genome folding in individual cells. The principal investigator will conduct systematic, large-scale genetic and chemical perturbation screens utilizing single-cell whole-genome 3D structure measurement and transcriptome analysis as phenotypic outcomes. Through integration of high-precision single-cell sequencing technologies and advanced computational algorithms, the research aims to establish a comprehensive rulebook of DNA folding mechanisms that control gene expression and determine normal cellular physiology and disease states. The project addresses a significant technological gap in 3D genomics research by developing and implementing large-scale perturbative tools and datasets that have historically been unavailable. Rather than the current labor-intensive, one-protein-at-a-time approach to genome perturbation, this award funds the creation of systematic screening capabilities that will generate first-of-its-kind integrative data on genome-wide DNA organization. The five-year research program will leverage the principal investigator's previous pioneering work in solving the first single-cell 3D human genome structure to advance fundamental understanding of genome folding principles, with direct implications for both normal cellular function and disease biology.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $385.0k | 2/20/26 |